1-10% (selected)
Urinary tract infection (7%),Headache (7%),Hypersensitivity-related events (<4%; eg, urticaria, facial edema),Peripheral edema (<4%; increased incidence when coadministered with thiazolidinediones),Upper respiratory tract infection (3%),Gastroenteritis (2%),Hypoglycemia (1.6%)
Frequency Not Defined
Increased creatinine phosphokinase,Increased creatinine,Idiopathic thrombocytopenic purpura rash